Quote | Super Quote
Super Quote   |   Detail Quote   |   Interactive Chart   |   Transaction   |   Related News   |   Related Securities   |   Company Information   |   Dividend Records   |   Short Sell
02162 KEYMED BIO-B
RT Nominal down30.550 -0.400 (-1.292%)
Latest  |  Final  |  Interim
Non-current Assets
2023/12 - Final
RMB(K¥)
%Chg
(Final to Final)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
2020/12
RMB(K¥)
2019/12
RMB(K¥)
Investment Properties0--0000
Property, plant, equip. & others803,34745.125%553,556139,419100,99296,465
Land & other Lease Assets90,390192.733%30,87838,11123,82328,902
Intangible Assets1,110-25.802%1,4961,1041090
Interests in Asso. & JCEs5,822-44.920%10,57020,28100
Other Non-current Assets42,72265.320%25,842153,59124,10414,806

943,39151.587%622,342352,506149,028140,173
Current Assets
2023/12 - Final
RMB(K¥)
%Chg
(Final to Final)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
2020/12
RMB(K¥)
2019/12
RMB(K¥)
Inventories56,35426.652%44,49516,3936,8463,306
Trade Receivables16,091--0000
Cash & Bank Balances851,02940.883%604,0701,520,619199,409432,608
Other Current Assets2,016,057-24.249%2,661,4092,044,937174,66282,491
Assets Held for Sale0--0000

2,939,531-11.192%3,309,9743,581,949380,917518,405
Current Liabilities
2023/12 - Final
RMB(K¥)
%Chg
(Final to Final)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
2020/12
RMB(K¥)
2019/12
RMB(K¥)
Trade Payables29,48897.734%14,9132,7843,4183,478
S-T Debt & Leases65,252-9.675%72,24111,7244,1784,430
Other Current Liabilities219,440-24.989%292,54597,56772,64463,682
Liab asso w/ Assets Held for Sale0--0000

314,180-17.256%379,699112,07580,24071,590
Net Current Assets2,625,351-10.406%2,930,2753,469,874300,677446,815
Total Assets Less Current Liabilities3,568,7420.454%3,552,6173,822,380449,705586,988
Non-current Liabilities
2023/12 - Final
RMB(K¥)
%Chg
(Final to Final)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
2020/12
RMB(K¥)
2019/12
RMB(K¥)
L-T Debt & Leases353,457610.781%49,72826,98520,31424,271
Other Non-current Liabilities228,47239.592%163,671150,0131,524,194838,672

581,929172.695%213,399176,9981,544,508862,943
Capital and Reserves
2023/12 - Final
RMB(K¥)
%Chg
(Final to Final)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
2020/12
RMB(K¥)
2019/12
RMB(K¥)
  Share Capital169-0.588%1701714545
  Reserves2,986,142-10.598%3,340,1183,650,799(1,094,583)(276,000)
  Others0--0000
Shareholders' Funds2,986,311-10.597%3,340,2883,650,970(1,094,538)(275,955)
Non-controlling Interests502--(1,070)(5,588)(265)0
Others0--0000

2,986,813-10.554%3,339,2183,645,382(1,094,803)(275,955)
Commitments and Contingent Liabilities
2023/12 - Final
RMB(K¥)
%Chg
(Final to Final)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
2020/12
RMB(K¥)
2019/12
RMB(K¥)
Commitments----897254,3451,97010,227
Contingent Liabilities----0000
Remarks:  Real time quote last updated: 25/07/2024 15:41
  Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service
Security Code
Company Name (Chi/Eng/Keywords)
Industry
Profit / (Loss) Attributable to Shareholders (¥)RMB -359,357,000
%Change16.631%
EPS / (LPS)RMB -1.370
NBV Per Share (¥)RMB 10.675
A Member of HKET Holdings
Customer Service Hotline:(852) 2880 7004     Customer Service Email:cs@etnet.com.hk
Copyright 2024 ET Net Limited. http://www.etnet.com.hk ET Net Limited, HKEx Information Services Limited, its Holding Companies and/or any Subsidiaries of such holding companies, and Third Party Information Providers endeavour to ensure the availability, completeness, timeliness, accuracy and reliability of the information provided but do not guarantee its availability, completeness, timeliness, accuracy or reliability and accept no liability (whether in tort or contract or otherwise) any loss or damage arising directly or indirectly from any inaccuracies, interruption, incompleteness, delay, omissions, or any decision made or action taken by you or any third party in reliance upon the information provided. The quotes, charts, commentaries and buy/sell ratings on this website should be used as references only with your own discretion. ET Net Limited is not soliciting any subscriber or site visitor to execute any trade. Any trades executed following the commentaries and buy/sell ratings on this website are taken at your own risk for your own account.